Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosomal acidification machinery and pH-dependent lysosomal enzymes constitute a critical cellular system responsible for the degradation and recycling of biological macromolecules. The primary component of the acidification machinery is the vacuolar-type H+-ATPase (V-ATPase), a multi-subunit ATP-dependent proton pump that maintains the lysosomal lumen at an acidic pH of approximately 4.5 to 5.0 (Forgac, 2007). This acidic environment is essential for the activation and catalytic efficiency of over 60 different pH-dependent acid hydrolases, including cathepsins, glycosidases, and sulfatases (Mindell, 2012). Beyond degradation, this system plays a pivotal role in nutrient sensing via the mTORC1 pathway, vesicle trafficking, and bone resorption by osteoclasts (Zoncu et al., 2011). Dysregulation of these components is central to the pathogenesis of lysosomal storage disorders, neurodegenerative diseases like Parkinson's and Alzheimer's, and various cancers where V-ATPase overexpression facilitates metastasis (Colacurcio & Nixon, 2016). Therapeutic strategies include V-ATPase inhibitors for cancer and osteoporosis, as well as pharmacological chaperones or enzyme replacement therapies to restore hydrolase function in genetic disorders (Parenti et al., 2015).
Inhibition of V-ATPase-mediated proton translocation; pharmacological chaperoning to stabilize misfolded enzymes; enzyme replacement therapy to restore catalytic activity; modulation of lysosomal pH.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal acidification machinery and pH-dependent lysosomal enzymes (V-ATPase/Hydrolase System).